Status:
COMPLETED
The Swedish Birth Seat Trial
Lead Sponsor:
Helsingborgs Hospital
Collaborating Sponsors:
The Stig & Ragna Gorthon Foundation, Helsingborg
Conditions:
Instrumental Vaginal Births
Oxytocin Augmentation for Labor
Eligibility:
FEMALE
Phase:
NA
Brief Summary
The purpose of this study is to determine whether birth on a birthing seat will effect numbers of instrumentally assisted vaginal births, vaginal traumas, blood loss,use of artificial oxytocin for lab...
Eligibility Criteria
Inclusion
- nulliparous women who understood the Swedish language sufficiently well to receive information and give informed consent
- a normal pregnancy,singleton fetus in cephalic presentation
- spontaneous onset of labor occurring between gestational weeks 37 + 0 and 41 + 6
- Body Mass Index less (BMI) than thirty
- gestational diabetes not requiring medical treatment
- women who were planning a vaginal birth after a caesarean section (VBAC)
- women induced because of spontaneous rupture of membranes with no spontaneous contractions for longer than twenty-four hours
Exclusion
- multiparous women
- birth before gestational week 37
- breech presentation
- maternal BMI more than 30
- multiple pregnancy
- infectious disease
- pre-eclampsia or other conditions requiring medical care
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
1002 Patients enrolled
Trial Details
Trial ID
NCT01182038
Start Date
November 1 2007
End Date
July 1 2009
Last Update
August 16 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsingborgs Hospital
Helsingborg, Skåne County, Sweden, 25187